Bora CDMO Bora CDMO

X

List of API Suppliers of (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime API listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
Flag France
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Caution USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
2364
Status
Inactive
Fees Paid
N/A
 
Filing Details
NORGESTERAL ACETATE OXIME
Issue/Submission Date
1974-11-26
Sanofi Company Banner

EMWA 2024

Not Confirmed

envelop Contact Supplier
Flag Netherlands
Digital Content Digital Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
Flag Israel
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
14241
Status
Active
Fees Paid
N/A
 
Filing Details
NORGESTIMATE BULK DRUG SUBSTANCE
Issue/Submission Date
1999-06-25
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Found CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
15649
CEP 2023-354 - Rev 00
Status
Active
Fees Paid
Reviewed
Valid
 
Filing Details
NORGESTIMATE
Norgestimate, Optimised process SM-...
Issue/Submission Date
2001-10-04
2024-02-16
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Found CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
21518
CEP 2017-189 - Rev 01
Status
Active
Fees Paid
N/A
Valid
 
Filing Details
NORGESTIMATE USP
Norgestimate
Issue/Submission Date
2008-04-09
2023-09-28
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
33444
Status
Active
Fees Paid
Reviewed
 
Filing Details
NORGESTIMATE USP (NP)
Issue/Submission Date
2019-02-05
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Caution USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
19327
Status
Inactive
Fees Unpaid
N/A
 
Filing Details
NORGESTIMATE
Issue/Submission Date
2006-04-06
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Argentina
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Caution CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
16271
R0-CEP 2010-012 - Rev 00
Status
Active
Fees Paid
N/A
Expired
 
Filing Details
NORGESTIMATE- DEXNORGESTREL ACETIME
Norgestimate
Issue/Submission Date
2002-11-26
2011-11-17
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
22726
Status
Active
Fees Paid
N/A
 
Filing Details
NORGESTIMATE USP
Issue/Submission Date
2009-04-15
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Hungary
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Caution USDMF

CEP/COS

Found CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
5708
R1-CEP 2009-125 - Rev 01
Status
Inactive
Fees Unpaid
N/A
Valid
 
Filing Details
NORGESTIMATE
Norgestimate
Issue/Submission Date
1985-01-21
2021-12-02
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Hungary
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
19429
Status
Active
Fees Unpaid
Reviewed
 
Filing Details
NORGESTIMATE USP
Issue/Submission Date
2006-05-15
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Israel
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
R1-CEP 2009-305 - Rev 00
Status
Valid
 
Filing Details
Norgestimate
Issue/Submission Date
2016-11-29
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag France
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Spain
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Italy
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Found CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
R0-CEP 2021-049 - Rev 02
Status
Valid
 
Filing Details
Norgestimate, Optimized process
Issue/Submission Date
2022-10-10
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Looking for 35189-28-7 / Norgestimate API manufacturers, exporters & distributors?

Norgestimate manufacturers, exporters & distributors 1

68

PharmaCompass offers a list of Norgestimate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Norgestimate manufacturer or Norgestimate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Norgestimate manufacturer or Norgestimate supplier.

PharmaCompass also assists you with knowing the Norgestimate API Price utilized in the formulation of products. Norgestimate API Price is not always fixed or binding as the Norgestimate Price is obtained through a variety of data sources. The Norgestimate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Norgestimate

Synonyms

Dexnorgestrel acetime, 35189-28-7, Anti-norgestimate, Norgestimate, e-, Norgestimato, Norgestimatum

Cas Number

35189-28-7

Unique Ingredient Identifier (UNII)

NKX8DN6TY9

About Norgestimate

Norgestimate was first described in the literature in 1977. It was developed by Ortho Pharmaceutical Corporation as part of an effort to develop new hormonal contraceptives with reduced adverse effects. It is commonly formulated with [ethinylestradiol] as a combined oral contraceptive that can also be used to treat moderate acne vulgaris. Norgestimate was granted FDA approval on 29 December 1989.

(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime Manufacturers

A (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime, including repackagers and relabelers. The FDA regulates (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime Suppliers

A (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime supplier is an individual or a company that provides (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime active pharmaceutical ingredient (API) or (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime finished formulations upon request. The (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime suppliers may include (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime API manufacturers, exporters, distributors and traders.

click here to find a list of (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime Manufacturers | Traders | Suppliers

(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime Manufacturers, Traders, Suppliers 1
55

We have 14 companies offering (17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime

Get in contact with the supplier of your choice:

  1. Sanofi
  2. Aspen API
  3. Teva API
  4. ASG Biochem
  5. CHEMO
  6. Gador SA
  7. Gedeon Richter
  8. Industriale Chimica s.r.l.
  9. Lupin Ltd
  10. Merck & Co
  11. Sicor Societa Italiana Corticosteroidi Srl
  12. Sterling Spa
  13. Teva Pharmaceutical Industries
  14. Unipex
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY